Common Contracts
2 similar License Agreement contracts by Correvio Pharma Corp.
LICENSE AGREEMENTLicense Agreement • January 23rd, 2021 • New York
This License Agreement (this "Agreement"), effective as of May 5, 2016 (the "Effective Date"), is made by and between Durata Therapeutics International B.V., a private limited company registered in the Netherlands with offices at Barbara Strozzilaan 101, Spaces Zuida, Amsterdam, the Netherlands ("Allergan"), and Correvio International Sárl, a Swiss corporation with offices at Rue des Alpes 21, Case postale 1674, 1201 Geneva, Switzerland ("Licensee"). Each of Allergan and Licensee is referred to herein individually as a "Party" and collectively as the "Parties." Certain capitalized terms have the meanings provided in Article I below.
LICENSE AGREEMENT Dated as of May 5, 2016 by and between DURATA THERAPEUTICS INTERNATIONAL B.V. and CORREVIO INTERNATIONAL SÁRLLicense Agreement • July 12th, 2018 • Correvio Pharma Corp. • Pharmaceutical preparations • New York
This License Agreement (this "Agreement"), effective as of May 5, 2016 (the "Effective Date"), is made by and between Durata Therapeutics International B.V., a private limited company registered in the Netherlands with offices at Barbara Strozzilaan 101, Spaces Zuida, Amsterdam, the Netherlands ("Allergan"), and Correvio International Sárl, a Swiss corporation with offices at Rue des Alpes 21, Case postale 1674, 1201 Geneva, Switzerland ("Licensee"). Each of Allergan and Licensee is referred to herein individually as a "Party" and collectively as the "Parties." Certain capitalized terms have the meanings provided in Article I below.
